In one paragraphArticle in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Hao Zhang *Stanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-2646-0959 Rihua Huang *Stanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-5399-0074 Phung N ThaiDepartment of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA (H.Z., P.N.T.).ORCID 0000-0001-7344-150X Lu RenStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-9731-8562 Wenjuan ZhuStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0003-2724-4825 Yuanyuan DaiStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.
Wenqiang LiuStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-2323-7962 Mengjie XieStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0003-4415-8267 Xiu LiuStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0001-7818-8312 Renke TanStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-7669-3996 Xiaochun YangStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-9937-965X Xu CaoStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-8368-6727 Xuekun WuStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.
Matthew A WuGreenstone Biosciences, Palo Alto, CA (R.V.S., M.A.W.).
Christopher CaridiSarafan ChEM-H Nucleus, High-Throughput Screening and Innovative Medicines Accelerator (IMA; C.C., D.S.-C.), Stanford University School of Medicine, Stanford, CA.
David Solow-CorderoSarafan ChEM-H Nucleus, High-Throughput Screening and Innovative Medicines Accelerator (IMA; C.C., D.S.-C.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-9886-5058 Joseph C WuStanford Cardiovascular Institute (H.Z., R.H., L.R., W.Z., Y.D., W.L., M.X., X.L., R.T., X.Y., X.C., X.W., J.C.W.), Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-6068-8041 Funding
Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCsR01HL130020 · NHLBI · STANFORD UNIVERSITY · PI Ronglih Liao, MARK MERCOLA · 2016 to 2026
$7.3MElucidating Sex Differences in Radiation-induced Cardiotoxicity with Cell Village iPSCsU01AI183953 · NIAID · STANFORD UNIVERSITY · PI Adam J Chicco, Joseph C. Wu · 2024 to 2026
$1.6MAI-driven Drug Discovery Targeting Cardiac Fibrosis in Aging HeartUG3AG097135 · NIA · STANFORD UNIVERSITY · PI SAYED, NAZISH, WU, JOSEPH C. · 2025 to 2025
$900kTargeting Immune-Fibroblast Crosstalk in Genetic Dilated CardiomyopathyR01HL185054 · NHLBI · STANFORD UNIVERSITY · PI Wing H. WONG, Joseph C. Wu · 2026 to 2026
$769kMechanisms of Tyrosine Kinase Inhibitor-induced Sinoatrial Node DysfunctionK99HL179374 · NHLBI · STANFORD UNIVERSITY · PI Lu Ren · 2026 to 2026
$153kNHLBI NIH HHS K99 HL179374NHLBI NIH HHS R01 HL130020NHLBI NIH HHS R01 HL185054NIAID NIH HHS U01 AI183953NIA NIH HHS UG3 AG097135
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
extracellular matrixfibrosisinduced pluripotent stem cellsmyocytes, cardiacorganoids
Identifiers
PMID42689334
PMCPMC13649265
What OpenQuestion holds
Textmetadata
Read underepoch 390